{"title":"The Landscape of BRCA1-Associated Post-Translational Modifications","authors":"Nethma Hewa Waduge, Junhua Xiao, Gregory M. Davis","doi":"10.1002/cbin.70186","DOIUrl":null,"url":null,"abstract":"<p>The BRCA1-BARD1 complex is a vital protein that promotes homologous recombination, acting through its E3 ubiquitin ligase activity. Although ubiquitination remains its only confirmed enzymatic function, emerging evidence suggests that the complex influences a broad range of post-translational modifications (PTMs), including methylation, phosphorylation, acetylation, and PARylation, involving other proteins. This review examines findings from various eukaryotic biological models to elucidate how BRCA1 regulates key PTMs. We explore how BRCA1 shapes chromatin architecture by modulating key PTMs such as ubiquitination, methylation, and acetylation. While BRCA1-driven changes in methylation appear to have widespread effects throughout the cell, its influence on ubiquitination and acetylation tends to be more region- or site-specific. Furthermore, this review discusses BRCA1's role in modifying specific target proteins, such as PLK-1, Aurora A, and p53, and explores its involvement in non-ubiquitin PTMs. Beyond its well-established role in DNA repair, BRCA1 also contributes to other cellular processes involving non-ubiquitin PTMs, such as in meiotic sex chromosome inactivation, which is also detailed in this review. Collectively, this review expands the functional landscape of BRCA1 beyond DNA repair, providing new insights into its regulatory impact across various post-translational pathways.</p>","PeriodicalId":9806,"journal":{"name":"Cell Biology International","volume":"50 7","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2026-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cbin.70186","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell Biology International","FirstCategoryId":"99","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cbin.70186","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The BRCA1-BARD1 complex is a vital protein that promotes homologous recombination, acting through its E3 ubiquitin ligase activity. Although ubiquitination remains its only confirmed enzymatic function, emerging evidence suggests that the complex influences a broad range of post-translational modifications (PTMs), including methylation, phosphorylation, acetylation, and PARylation, involving other proteins. This review examines findings from various eukaryotic biological models to elucidate how BRCA1 regulates key PTMs. We explore how BRCA1 shapes chromatin architecture by modulating key PTMs such as ubiquitination, methylation, and acetylation. While BRCA1-driven changes in methylation appear to have widespread effects throughout the cell, its influence on ubiquitination and acetylation tends to be more region- or site-specific. Furthermore, this review discusses BRCA1's role in modifying specific target proteins, such as PLK-1, Aurora A, and p53, and explores its involvement in non-ubiquitin PTMs. Beyond its well-established role in DNA repair, BRCA1 also contributes to other cellular processes involving non-ubiquitin PTMs, such as in meiotic sex chromosome inactivation, which is also detailed in this review. Collectively, this review expands the functional landscape of BRCA1 beyond DNA repair, providing new insights into its regulatory impact across various post-translational pathways.
期刊介绍:
Each month, the journal publishes easy-to-assimilate, up-to-the minute reports of experimental findings by researchers using a wide range of the latest techniques. Promoting the aims of cell biologists worldwide, papers reporting on structure and function - especially where they relate to the physiology of the whole cell - are strongly encouraged. Molecular biology is welcome, as long as articles report findings that are seen in the wider context of cell biology. In covering all areas of the cell, the journal is both appealing and accessible to a broad audience. Authors whose papers do not appeal to cell biologists in general because their topic is too specialized (e.g. infectious microbes, protozoology) are recommended to send them to more relevant journals. Papers reporting whole animal studies or work more suited to a medical journal, e.g. histopathological studies or clinical immunology, are unlikely to be accepted, unless they are fully focused on some important cellular aspect.
These last remarks extend particularly to papers on cancer. Unless firmly based on some deeper cellular or molecular biological principle, papers that are highly specialized in this field, with limited appeal to cell biologists at large, should be directed towards journals devoted to cancer, there being very many from which to choose.